Arcus Biosciences
David Schmeidler is an accomplished professional with extensive experience in clinical programming and data management within the pharmaceutical industry. Currently serving as the Head of Clinical Programming at Arcus Biosciences since September 2023, David previously held the position of Senior Director of Data Management and Statistical Programming at REGENXBIO Inc. from August 2016 to September 2023. David's career includes significant roles such as Senior Manager of Clinical Programming at Otsuka Pharmaceutical Companies (U.S.) from September 2013 to August 2016, Principal Statistical Programmer/Asset Lead at PAREXEL from November 2012 to September 2013, and Project Lead for Clinical SAS Programming at MedImmune from February 2008 to November 2012.
This person is not in any offices
Arcus Biosciences
3 followers
Arcus Biosciences is a company creating new cancer therapeutics through the utilization of emerging insights in immunology. Arcus was formed in 2015 by a group of researchers from the biotechnology and pharmaceutical industries.